Then, we experimentally verified that PHF23 activates the ERK signaling pathway by stabilizing ACTN4, thereby promoting proliferation, migration, and chemoresistance of lung cancer cells in vitro and in vivo. This evidence concerns the gene PHF23 and lung carcinoma.